2022 ACR/AAHKS Guidelines for Management of
Apr 6, 2022 · References. American College of Rheumatology & American Association of Hip and Knee Surgeons. 2022 American College of Rheumatology/American Association of Hip and …
Facet Hypertrophy | Diagnosis & Disease Information
Sep 12, 2022 · Etiology and Risk Factors. Spondylosis, or degeneration of the spine, is the most common cause of facet joint disease. Osteoarthritis, or degeneration that is due to natural …
ACR Releases 2024 Guideline Summary for Lupus Nephritis
Nov 25, 2024 · Recommended treatment includes pulse intravenous glucocorticoids (250-1000 mg/day for 1-3 days) transitioning to oral dosing (≤0.5 mg/kg/day), with the goal of tapering to …
Hydroxyapatite Crystal Deposition Disease (HADD)
Nov 15, 2022 · History and Epidemiology. A typically uniarticular condition, hydroxyapatite (HA) crystal deposition disease (HADD) is marked by the presence of hydroxyapatite crystals in the …
Lorecivivint Shows Promising Efficacy for Managing Knee …
Nov 19, 2024 · Lorecivivint (LOR) demonstrated significant efficacy and safety for managing symptoms of moderate to severe knee osteoarthritis (OA) and improving patient reported …
Calcium Pyrophosphate Deposition Disease (CPPD)
Oct 5, 2022 · History and Epidemiology. Calcium pyrophosphate deposition disease (CPPD) is a crystal deposition arthropathy that involves the synovial and periarticular tissues, 1 often …
Neurological Manifestations of Sjogren Syndrome - Rheumatology …
Mar 23, 2018 · Sjogren syndrome is an autoimmune disease characterized by dysfunction of exocrine glands that results in symptoms of dry mouth and dry eyes. 1 Primary Sjogren …
Rare and Unusual Clinical Presentations of Gout
Apr 19, 2024 · Gout is a type of inflammatory arthritis characterized by the deposition of monosodium urate crystals and the formation of tophi in tissues, typically in or around the …
Undifferentiated Connective Tissue Disease - Rheumatology Advisor
Aug 9, 2022 · Undifferentiated connective tissue disease (UCTD) is a diagnosis of exclusion. Patients who present with clinical and serolotical manifestations that suggest a systemic …
FDA Roundup: Rheumatology Drug Alerts 2024
Mar 5, 2024 · Throughout 2024, the United States Food and Drug Administration (FDA) approved new drugs for the treatment of osteoporosis, rheumatoid arthritis (RA), juvenile idiopathic …